Aflac Inc.
Aflac Incorporated (AFL)
Overview
Aflac Incorporated is a supplemental health and life insurance holding company headquartered at 1932 Wynnton Road, Columbus, Georgia. It operates in the insurance sector, with the majority of its business conducted in Japan and the remainder in the United States. For fiscal year 2025, Aflac reported total revenue of approximately $17.16 billion (down from $18.93 billion in 2024, reflecting currency and product mix effects) and net income of about $3.65 billion. The company employed roughly 12,700 people worldwide as of FY2025 — about 6,800 in Japan, 5,100 in the U.S., and the remainder in corporate/other functions — and holds total assets of well over $100 billion. Aflac is widely recognized in the U.S. for its animated duck advertising mascot and is famous for pioneering supplemental cancer insurance.
What They Do & How They Make Money
Aflac sells supplemental insurance — policies that pay cash benefits directly to policyholders when they experience a covered accident, illness, or medical event, supplementing (rather than replacing) primary health insurance or income. Its classic products include cancer insurance (which it pioneered in 1958), accident insurance, disability income, critical illness/critical care, hospital indemnity, dental, vision, and life insurance. The company makes money the way most insurers do: it collects premiums from policyholders, invests the resulting float in a large fixed-income-heavy investment portfolio, and pays out claims and benefits over time, aiming for premiums plus investment income to exceed claims, expenses, and reserve requirements. A defining feature of Aflac's U.S. distribution model is payroll deduction — most U.S. policies are sold and paid for through employer worksites, where independent agents and brokers enroll employees who then pay premiums automatically out of their paychecks, giving Aflac a low-cost, high-retention distribution channel. In Japan, Aflac has historically distributed through a large network of individual agencies, banks, and strategic alliances — most notably with Japan Post and Dai-ichi Life — giving it deep penetration into the Japanese insurance market, where it is the largest insurer measured by individual policies in force.
Business Segments
Aflac reports results primarily through two operating segments plus a corporate segment:
- Aflac Japan: The company's largest business by revenue and assets — Japan represented roughly 53% of adjusted revenues and about 76% of total company assets in FY2025. It sells cancer, medical, nursing-care, and life insurance products to Japanese consumers through agencies, bank channels, and alliance partners (notably Japan Post and Dai-ichi Life). Aflac Japan's scale makes it the single largest insurance company in Japan by individual policies in force.
- Aflac U.S.: Sells supplemental coverage — accident, disability, critical illness, hospital indemnity, dental, vision, and life insurance — primarily through independent agents, brokers, and direct-to-consumer channels, targeting employers from small businesses to large corporations for payroll-deduction worksite enrollment.
- Corporate and Other: Includes the parent holding company, asset-management subsidiaries, reinsurance operations (including Aflac Re Bermuda, used to manage capital and risk across the group), and other support functions; this segment is not a revenue driver in the way the two insurance segments are.
Competitors
- U.S. supplemental/worksite insurance: Unum Group (and its Colonial Life subsidiary, a direct worksite-insurance competitor), MetLife, Cigna, Guardian Life, Voya Financial, Sun Life Financial, and Allstate (through its Allstate Benefits worksite unit) all compete for employer-sponsored supplemental and voluntary benefits business.
- Japan life/supplemental insurance: Dai-ichi Life (also an Aflac distribution partner), Nippon Life, Japan Post Insurance, Sony Life, MetLife Japan, and Prudential's Japanese operations compete for both traditional life insurance and cancer/medical supplemental products in Aflac's largest market.
- Broader life/health insurance: Large diversified insurers such as Prudential Financial, MassMutual, and Manulife compete at the margins for overlapping product lines, though Aflac's specific niche — payroll-deduction supplemental benefits — has fewer direct full-scale competitors than broad-line life and health insurers.
Competitive Position
Aflac's core competitive advantage is its long-entrenched position as the pioneer and largest player in supplemental/worksite insurance in both of its major markets. In Japan, decades of building relationships with individual agencies and a landmark, long-running distribution alliance with Japan Post give Aflac an unusually deep, hard-to-replicate distribution network in the world's third-largest insurance market — a moat reinforced by high customer retention on cancer and medical policies that Japanese consumers tend to hold for life. In the U.S., Aflac's first-mover advantage in payroll-deduction worksite marketing, combined with one of the most recognized advertising campaigns in American business (the Aflac duck), gives it strong brand recall and an efficient, low-churn distribution channel through employer relationships and independent agents.
Key risks and threats include Aflac's outsized reliance on the Japanese market, which exposes the company to yen/dollar currency fluctuations (a significant driver of reported revenue swings, as seen in the FY2025 revenue decline), low or negative Japanese interest rates that pressure investment income on its large yen-denominated bond portfolio, and a shrinking/aging Japanese population that constrains the growth of new policy sales over the long term. In the U.S., Aflac faces increasing competition for worksite-benefits distribution from both traditional insurers expanding into voluntary benefits and newer insurtech/benefits-administration platforms that are digitizing enrollment and disintermediating traditional agent relationships. Aflac also carries typical insurance-industry risks: investment portfolio risk (interest-rate and credit exposure), long-tail claims and reserve-adequacy risk on health-related products, and regulatory risk in both the heavily regulated U.S. state insurance system and Japan's insurance regulatory regime. Aflac has generally managed these risks through disciplined underwriting, a conservative investment approach, and steady capital return to shareholders via dividends and buybacks, though the notable FY2025 decline in both revenue and net income underscores the earnings volatility that currency and market conditions can introduce even for a well-established franchise.